SEC FORM 4
$137.28
Monte Rosa Therapeutics, Inc. (GLUE)
Sale of 13 shares at $10.56 per share.
Reporting Person Bowen Matthew · Officer Title Principal Accounting Officer · Transaction Code S
Traded Oct 5, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001193125-26-415540 · filed 2026-10-06 · View filing →